CLS

Celestica Files Form 20-F

Retrieved on: 
Monday, March 11, 2024

The annual report on Form 20-F can be accessed on the company's website at www.celestica.com in the Investor Relations section.

Key Points: 
  • The annual report on Form 20-F can be accessed on the company's website at www.celestica.com in the Investor Relations section.
  • The Form 20-F can also be viewed at www.sedarplus.com and at www.sec.gov .
  • The company's shareholders are entitled to receive copies of the Form 20-F free of charge.
  • Shareholders who have already requested a copy of the Form 20-F will receive this document in the mail.

Molecular Templates, Inc. Provides Interim Update

Retrieved on: 
Monday, March 4, 2024

Unique pharmacodynamic effects demonstrating potent Treg clearance and IL-2 increases were observed at the first dose level.

Key Points: 
  • Unique pharmacodynamic effects demonstrating potent Treg clearance and IL-2 increases were observed at the first dose level.
  • MTEM intends to initiate a study of MT-0169 in CD38+ acute leukemias in collaboration with MD Anderson Cancer Center.
  • Additional details on each of these participant’s clinical profile and response to the investigational treatment are provided below.
  • MTEM plans on initiating an investigator sponsored trial with MD Anderson Cancer Center to evaluate MT-0169 in relapsed or refractory CD38+ AML patients.

Celestica Announces Updates to its 2024 Annual and Special Meeting of Shareholders

Retrieved on: 
Wednesday, February 28, 2024

TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Celestica Inc. (“Celestica” or the “Corporation”) (NYSE, TSX: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world’s most innovative companies, today announced that the previously announced Annual and Special Meeting of its shareholders (the “Meeting”), to be held on Thursday, April 25, 2024 at 9:30 a.m. EDT, has been changed from a virtual-only format to a hybrid format.

Key Points: 
  • TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Celestica Inc. (“Celestica” or the “Corporation”) (NYSE, TSX: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world’s most innovative companies, today announced that the previously announced Annual and Special Meeting of its shareholders (the “Meeting”), to be held on Thursday, April 25, 2024 at 9:30 a.m. EDT, has been changed from a virtual-only format to a hybrid format.
  • Celestica welcomes the participation of shareholders who will be able to attend the Meeting in-person at Celestica’s head office at 5140 Yonge Street, Suite 1900, Toronto, Ontario.
  • Shareholders may also attend and participate in the Meeting virtually via a live audio-only webcast.
  • At the Meeting, in addition to the previously announced items of formal business, shareholders will be asked to confirm the amending and restating of the Corporation’s By-Law 1 to remove the Canadian residency requirement for members of the Board of Directors.

TRU Simulation Awarded the Multi-Engine Training System Ground Based Training System Contract

Retrieved on: 
Friday, March 1, 2024

TRU Simulation announced today the company has been awarded the Multi-Engine Training System (METS) Ground Based Training System (GBTS) contract by Naval Air Warfare Center – Training Systems Division (NAWCTSD).

Key Points: 
  • TRU Simulation announced today the company has been awarded the Multi-Engine Training System (METS) Ground Based Training System (GBTS) contract by Naval Air Warfare Center – Training Systems Division (NAWCTSD).
  • View the full release here: https://www.businesswire.com/news/home/20240229824322/en/
    TRU Simulation Multi-Engine Training System (METS) Ground Based Training System (GBTS) (Photo: Business Wire)
    TRU Simulation + Training Inc., an affiliate of Textron Aviation Inc. , is a Textron Inc. (NYSE:TXT) company that designs, manufactures and delivers high-fidelity training devices and full-motion simulators for civil and defense customers.
  • “We are honored the U.S. Navy has selected TRU Simulation to fulfill its modeling and simulation training needs by leveraging TRU’s history of building high-fidelity training devices,” said Jerry Messaris, vice president and general manager, TRU Simulation.
  • The TRU Simulation team is pleased to support them in this mission.”
    The contract was awarded through a full and open competition.

NJFX Completes Acquisition of Critical Transatlantic Connectivity Assets from SubCom

Retrieved on: 
Tuesday, February 27, 2024

WALL TOWNSHIP, N.J. , Feb. 27, 2024 /PRNewswire/ -- Today, NJFX Utility Service LLC, a wholly owned subsidiary of NJFX, announced the successful acquisition of key infrastructure assets from SubCom LLC, originally developed in 2001.

Key Points: 
  • WALL TOWNSHIP, N.J. , Feb. 27, 2024 /PRNewswire/ -- Today, NJFX Utility Service LLC, a wholly owned subsidiary of NJFX, announced the successful acquisition of key infrastructure assets from SubCom LLC, originally developed in 2001.
  • These critical infrastructure assets required maintenance, which involves use of complicated and scarce marine expertise.
  • The number one priority is always life safety which makes this an expensive maintenance exercise in preserving US Critical Infrastructure.
  • Gil Santaliz, the CEO of NJFX, further emphasized the investment's significance, "We have invested close to $2 million to ensure these critical assets are ready for the next 30 years of use.

GeminiBio Appoints Mike Guerra to its Board of Directors

Retrieved on: 
Tuesday, February 20, 2024

FORT LAUDERDALE, Fla. and WEST SACRAMENTO, Calif., Feb. 20, 2024 /PRNewswire/ -- Gemini BioProducts Holding, Inc. ("GeminiBio" or the "Company"), a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Florida-based healthcare private equity firm, announced the appointment of Mike Guerra to its Board of Directors.

Key Points: 
  • FORT LAUDERDALE, Fla. and WEST SACRAMENTO, Calif., Feb. 20, 2024 /PRNewswire/ -- Gemini BioProducts Holding, Inc. ("GeminiBio" or the "Company"), a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Florida-based healthcare private equity firm, announced the appointment of Mike Guerra to its Board of Directors.
  • Mr. Guerra serves as President and Chief Executive Officer of California Life Sciences (CLS), California's most impactful and influential trade association advocating for California's life sciences industry.
  • In addition, Mr. Guerra currently sits on the Board of Directors for California Life Sciences (CLS), California Life Sciences Institute (CLSI) and serves as Vice Chair of the Council of State Bioscience Associations (CSBA).
  • Mike Guerra added "I am thrilled to join GeminiBio's board of directors and support their continued success and growth in California, and across the US.

New Study Published in Journal of Medical Regulation Affirms Removing Barriers to PA Practice Improves Patient Access to High-quality Care

Retrieved on: 
Tuesday, February 13, 2024

ALEXANDRIA, VA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Removing barriers to physician associate/assistant (PA) practice improves access to high-quality, cost-effective care and maintains patient safety, according to an article published today in the Journal of Medical Regulation (JMR).

Key Points: 
  • ALEXANDRIA, VA, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Removing barriers to physician associate/assistant (PA) practice improves access to high-quality, cost-effective care and maintains patient safety, according to an article published today in the Journal of Medical Regulation (JMR).
  • The research also demonstrated that almost all PA practice reforms lead to a reduction in MMPRs for PAs and physicians.
  • “Modernizing PA practice laws will strengthen team-based care and expand patient access at a time when so many communities are struggling to keep up with patient demands,” AAPA CEO Lisa M. Gables, CPA, said.
  • “In fact, more than two-fifths of U.S. adults say their community does not have the resources needed to keep people healthy .

Kelly Ahuja Appointed to Celestica’s Board of Directors

Retrieved on: 
Tuesday, January 30, 2024

TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Celestica Inc. (TSX: CLS) (NYSE: CLS), a leader in design, manufacturing and supply chain solutions for the world’s most innovative companies, is pleased to announce the appointment of Kulvinder (Kelly) Ahuja to its Board of Directors effective January 29, 2024.

Key Points: 
  • TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Celestica Inc. (TSX: CLS) (NYSE: CLS), a leader in design, manufacturing and supply chain solutions for the world’s most innovative companies, is pleased to announce the appointment of Kulvinder (Kelly) Ahuja to its Board of Directors effective January 29, 2024.
  • “I’m pleased to welcome Kelly to the Board of Directors of Celestica,” said Mike Wilson, Chair, Celestica’s Board of Directors.
  • “Kelly brings extensive industry knowledge and leadership acumen that will be valuable to the Board as we continue to strive to create shareholder value.”
    Mr. Ahuja has more than three decades of experience in networking and telecommunications.
  • Previously, Mr. Ahuja spent 18 years at Cisco where in his last role, he led the Service Provider Business, covering routing, optical, mobility, video, and cloud technologies.

Celestica Announces 2024 Annual and Special Meeting of Shareholders

Retrieved on: 
Tuesday, January 30, 2024

TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Celestica Inc. (“Celestica” or the “Corporation”) (NYSE, TSX: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world’s most innovative companies, today announced that the Annual and Special Meeting of its Shareholders (the “Meeting”) will be held on Thursday, April 25, 2024 at 9:30 a.m. EDT in a virtual format.

Key Points: 
  • TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Celestica Inc. (“Celestica” or the “Corporation”) (NYSE, TSX: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world’s most innovative companies, today announced that the Annual and Special Meeting of its Shareholders (the “Meeting”) will be held on Thursday, April 25, 2024 at 9:30 a.m. EDT in a virtual format.
  • Celestica also announced that it has set Friday, March 8, 2024 as the record date for determining shareholders of the Corporation who are entitled to receive notice of, and to vote at, the Meeting.
  • Celestica will be using the notice-and-access method for delivering the Corporation’s proxy statement and related materials to shareholders eligible to participate at the Meeting.
  • The platform for the Meeting will provide shareholders the ability to listen to the Meeting live, submit questions and submit their vote during the Meeting.

Celestica Recognized as one of Canada’s Top 100 Employers for Young People for 2024

Retrieved on: 
Tuesday, January 23, 2024

TORONTO, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Celestica Inc. (NYSE, TSX: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world's most innovative companies, has been named one of Canada’s Top 100 Employers for Young People for 2024 by Mediacorp Canada Inc., organizers of the annual Canada’s Top 100 Employers project.

Key Points: 
  • TORONTO, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Celestica Inc. (NYSE, TSX: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world's most innovative companies, has been named one of Canada’s Top 100 Employers for Young People for 2024 by Mediacorp Canada Inc., organizers of the annual Canada’s Top 100 Employers project.
  • “We are honoured to be named among Canada’s Top 100 Employers for Young People in 2024,” said Rob Mionis, President and Chief Executive Officer, Celestica.
  • The employers on this list are Canada's leaders in attracting, providing opportunity and retaining young employees to their organizations.
  • Celestica was selected based on the strength of its programs to attract and retain younger workers, including benefits, internships, mentorship, training and career management initiatives.